OK Biotech Co., Ltd. (4155.TW) Stock
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips.
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
About OK Biotech Co., Ltd.
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.
OK Biotech Co., Ltd. is led by CEO Jia-De Lai, employs 62 people, headquartered in Hsinchu City, TW, publicly traded since 2012.
OK Biotech Co., Ltd. (4155.TW) stock trades at $16.55 with a market capitalization of $1.94B. The stock is valued at a price-to-earnings (P/E) ratio of 8.76, price-to-book of 0.81, price-to-sales of 1.26. Over the past 52 weeks the stock has ranged between $14.34 and $18.41, and currently trades 10.1% below its 52-week high. It pays a dividend yielding 1.86%.
On profitability, OK Biotech Co., Ltd. generates a return on equity (ROE) of 10.29%, an operating margin of 11.85%, a net profit margin of 15.76%.
Official website: www.okbiotech.com
OK Biotech Co., Ltd. (4155.TW) — frequently asked questions
What is OK Biotech Co., Ltd. (4155.TW) stock price today?
OK Biotech Co., Ltd. (4155.TW) is currently trading at $16.55, up 2.48% today.
What is 4155.TW P/E ratio?
OK Biotech Co., Ltd.'s P/E ratio is 8.76. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 4155.TW return on equity (ROE)?
OK Biotech Co., Ltd.'s return on equity (ROE) is 10.29%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is OK Biotech Co., Ltd.'s market cap?
OK Biotech Co., Ltd. has a market capitalization of $1.94B.
Does 4155.TW pay a dividend?
Yes. OK Biotech Co., Ltd. currently yields 1.86%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 4155.TW carry?
OK Biotech Co., Ltd. has a debt-to-equity ratio of 0.41. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4155.TW's profit margin?
OK Biotech Co., Ltd. reports a net profit margin of 15.76% — the share of revenue left after every cost, including tax and interest.
What sector is 4155.TW in?
OK Biotech Co., Ltd. is classified under Healthcare, in the Medical Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4155.TW listed on?
OK Biotech Co., Ltd. trades on TAI under the ticker 4155.TW.
What is 4155.TW's 52-week range?
Over the last year OK Biotech Co., Ltd. has traded between $14.34 and $18.41.
Related Healthcare Stocks
Popular Stocks
Screens 4155.TW currently matches
On the figures above, OK Biotech Co., Ltd. passes the filters for 18 of our ready-made screens, among them Undervalued Stocks, Low PE Stocks, Low PB Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.